<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Burton BK</dc:creator>
  <dc:creator>Deegan PB</dc:creator>
  <dc:creator>Enns GM</dc:creator>
  <dc:creator>Guardamagna O</dc:creator>
  <dc:creator>Horslen S</dc:creator>
  <dc:creator>Hovingh GK</dc:creator>
  <dc:creator>Lobritto SJ</dc:creator>
  <dc:creator>Malinova V</dc:creator>
  <dc:creator>McLin VA</dc:creator>
  <dc:creator>Raiman J</dc:creator>
  <dc:creator>Di Rocco M</dc:creator>
  <dc:creator>Santra S</dc:creator>
  <dc:creator>Sharma R</dc:creator>
  <dc:creator>Sykut-Cegielska J</dc:creator>
  <dc:creator>Whitley CB</dc:creator>
  <dc:creator>Eckert S</dc:creator>
  <dc:creator>Valayannopoulos V</dc:creator>
  <dc:creator>Quinn AG</dc:creator>
  <dc:date>2015</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">OBJECTIVE
The aim of this study was to characterize key clinical manifestations of lysosomal acid lipase deficiency (LAL D) in children and adults.


METHODS
Investigators reviewed medical records of LAL D patients ages ≥5 years, extracted historical data, and obtained prospective laboratory and imaging data on living patients to develop a longitudinal dataset.


RESULTS
A total of 49 patients were enrolled; 48 had confirmed LAL D. Mean age at first disease-related abnormality was 9.0 years (range 0-42); mean age at diagnosis was 15.2 years (range 1-46). Twenty-nine (60%) were male patients, and 27 (56%) were &lt;20 years of age at the time of consent/assent. Serum transaminases were elevated in most patients with 458 of 499 (92%) of alanine aminotransferase values and 265 of 448 (59%) of aspartate aminotransferase values above the upper limit of normal. Most patients had elevated low-density lipoprotein (64% patients) and total cholesterol (63%) at baseline despite most being on lipid-lowering therapies, and 44% had high-density lipoprotein levels below the lower limit of normal. More than half of the patients with liver biopsies (n = 31, mean age 13 years) had documented evidence of steatosis (87%) and/or fibrosis (52%). Imaging assessments revealed that the median liver volume was ∼1.15 multiples of normal (MN) and median spleen volume was ∼2.2 MN. Six (13%) patients had undergone a liver transplant (ages 9-43.5 years).


CONCLUSION
This study provides the largest longitudinal case review of patients with LAL D and confirms that LAL D is predominantly a pediatric disease causing early and progressive hepatic dysfunction associated with dyslipidemia that often leads to liver failure and transplantation.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/214708</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1097/MPG.0000000000000935</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/26252914</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>Journal of pediatric gastroenterology and nutrition. - 2015</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Adolescent</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Adult</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Alanine Transaminase</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Aspartate Aminotransferases</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Child</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Child, Preschool</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Cholesterol</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Cholesterol Ester Storage Disease</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Fatty Liver</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Lipase</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Liver</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Liver Cirrhosis</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Liver Transplantation</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Longitudinal Studies</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Middle Aged</dc:subject>
  <dc:subject xmlns:ns19="xml" ns19:lang="en">Prospective Studies</dc:subject>
  <dc:subject xmlns:ns20="xml" ns20:lang="en">Spleen</dc:subject>
  <dc:subject xmlns:ns21="xml" ns21:lang="en">Sterol Esterase</dc:subject>
  <dc:subject xmlns:ns22="xml" ns22:lang="en">Wolman Disease</dc:subject>
  <dc:subject xmlns:ns23="xml" ns23:lang="en">Young Adult</dc:subject>
  <dc:title xmlns:ns24="xml" ns24:lang="en">Clinical Features of Lysosomal Acid Lipase Deficiency.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
